The 100 Days Mission seeks to deliver diagnostics, treatments & vaccines within 100 days of a pandemic threat. Today at #DevexUNGA81, our key partners @IPPSecretariat @DNDi @CEPIvaccines @UNITAID @MedsPatentPool discussed practical ways to turn that goal into readiness. #DiagnosisForAll

On BDBV, Sheila Mburu reflects on diagnostics availability: ''At Day 100 we still don’t have a true point-of-care test. This is essential for communities that don’t have access to centralised testing.'' @Mburu_Health #100DaysMission #UNGA81

The 100 Days Mission seeks to deliver diagnostics, treatments & vaccines within 100 days of a pandemic threat. At #DevexUNGA81, @IPPSecretariat, @DNDi, @CEPIvaccines, @FINDdx, @UNITAID & @MedsPatentPool will discuss turning that goal into readiness. 👉 dvx.cm/bgxtab

Chagas disease affects ~8 million people worldwide, yet reliable diagnostics remain out of reach for far too many. Through CUIDA Chagas, FIND and its partners are tackling the supply chain, regulatory, and procurement barriers limiting access across Bolivia, Brazil, Colombia, and Paraguay. Check out the latest project newsletter for key insights on Trypanosoma cruzi detection tools and recommendations to expand access across the region. 👇 cuidachagas.org/es/panoramaa… #DiagnosisForAll #ChagasDisease

➡️ FIND’s abstract: “From Months to Days: How Community Leadership Transformed Hepatitis C Care for People who inject drugs (PWIDs)” has been selected for the 12th International Viral Hepatitis Elimination Meeting (IVHEM) 2026 taking place from 3-4 September in Hiroshima, Japan. Read more to learn how operational bottlenecks to hepatitis care can be reduced by embedding lived experience into programme design and empowering communities as equal partners. Abstract available on page 37 of the official abstract book 📖 ve-ame.ams3.digitaloceanspac…

Global commitments are shifting into concrete action to improve access to essential medicines, diagnostics and medical devices for noncommunicable diseases. Availability and affordability of medicines, diagnostics and devices must be supported by: ✅ evidence-based selection and use ✅ stronger regulatory systems ✅ effective demand forecasting and procurement ✅ cohesive pricing policies ✅ inclusion in health benefit packages ✅ financed as part of UHC.

Ending non-communicable diseases requires all hands on deck: governments, donors, the private sector, and global partners. Together, we can #ActOnNCDs. Discover how @HelmsleyTrust is supporting our work: bit.ly/4gIzbNj

📢This Global Week for Action, learn more about FIND's work on NCDs: finddx.org/what-we-do/progra… #DiagnosisForAll #NCDs

⏰It's time to #LeadOnNCDs! 💪FIND has joined the Global Week for Action! Let's call on leaders to: ✅Implement NCD policies ✅Break down siloes in the response ✅Mobilise investments ✅Stay true to the promises ✅Involve people living w/ #NCDs actonncds.org/#ActOnNCDs #DiagnosisForAll

How can we expand sustainable access to life-saving HPV DNA testing for more women? With support from FIND, the Hai Phong Department of Health 🇻🇳 developed a co-payment model rooted in scientific evidence, policy frameworks, and local implementation capacity offering a clear roadmap for scalable cervical cancer screening. Learn more: piped.video/AFMQ4T33vuE?si=muT9…

Last week, we were delighted to welcome students from Zhengzhou University in China. Their curiosity, enthusiasm and interest in our work made the visit truly special. Thank you for spending time with us, we hope the experience inspires the next generation of global health leaders. #GlobalHealth #DiagnosisForAll

The Meghalaya Users Forum (MUF), in collaboration with Meghalaya AIDS Control Society (MACS), National Viral Hepatitis Control Programme (NVHCP), Meghalaya State Network of Positive People (MSNP) and Foundation for Innovative New Diagnostics (FIND), observed....

Community-led approaches work! This #WorldHepatitisDay2026, we celebrated the impact of the HEP CARE initiative in Meghalaya alongside NVHCP, MACS, MUF, & DREAM Mission. Together, we’re breaking down barriers, stigma, & hepatitis. #DiagnosisForAll #EndHepatitis

Testing delays and high costs shouldn't stand between people & a cure. In Meghalaya, the HEP-CARE project launched by FIND in partnership with @meghalayasacs & State Viral Hepatitis Control Programme is breaking down barriers for People Who Inject Drugs (PWID) by putting community & peer navigators at the center of hepatitis C care, cutting time to treatment by nearly four-fold. This #WorldHepatitisDay we call to remove the barriers that stand between people & the services that can save their lives.

This afternoon, I met up with Hajar Mat Noji, a PhD student in Health Economics and Health Technology Assessment at the University of Glasgow, at Toro’s Steakhouse in Manchester. I was interviewed for her thesis on, “Assessing cost-effectiveness and affordability of new expensive treatment options and impact on sustainability of health systems.” I shared the case study on Hepatitis C in Malaysia on how we made several critical policy decisions, from decentralising care from hospitals to community clinics, to driving the urgency of finding the “missing millions,” and maximizing the cost-saving impact of hepatitis C elimination programs aligned with the WHO’s 2030 target. Our overall progress speaks for itself. Working with the Foundation for Innovative New Diagnostics (FIND) on point-of-care testing, and securing access to affordable therapeutics (STORM-C-1 trial) for hepatitis C, coupled with the groundbreaking EASE study where we reduced treatment duration from 12 weeks to 8 weeks and slashing costs by a third without compromising efficacy. Today, Malaysia is actively working to find the missing millions of undiagnosed Hepatitis C patients, aiming for elimination by 2030. With improved point-of-care diagnostics and therapeutic access, the country is on track to drastically reduce and eliminate Hepatitis C and its complications, including liver cancer, cirrhosis, and liver failure

Over 80% of adults with diabetes live in LMICs, yet access to life-changing CGMs remains limited. With support from @HelmsleyTrust, FIND is launching ACCEDE 2.0 (2026–2029) in India and additional countries in Africa & SE Asia to break down barriers and make CGMs affordable & accessible. ➡️bit.ly/3RjgOFZ #DiagnosisForAll #GlobalHealth #DiabetesCare #HealthEquity #NCDs #CGM

The Board of FIND has announced that Dr. Ayoade Alakija will step down as Chair of the Board, effective 10 July 2026. The Board thanks Dr. Alakija for her service to FIND and acknowledges the time and commitment she has dedicated to the organization. The Board has appointed Professor Marcel Tanner as Interim Chair with immediate effect: finddx.org/publications-and-…

The UN HLM Political Declaration should recognise BDBV as a clear case for strengthening preparedness across emerging and re-emerging pathogens, with access built into R&D by design. 🧵4/4 Read the full statement: ippsecretariat.org/news/acce…

Today, 8PDPs launched a call for sustained EU funding for EDCTP — supporting 20+ years of Europe–Africa clinical research, capacity strengthening, and innovation for global health security. Learn more: finddx.org/wp-content/upload…

📢 Our latest newsletter is out now! A busy quarter for IPPS, with much of the focus on supporting the response to the ongoing Ebola Bundibugyo virus outbreak, plus advocacy ahead of September's UN High-Level Meeting on pandemic preparedness. Read it 👇 mailchi.mp/ippsecretariat/10…